Jump to main content

yr 〜
yr

Search results 17

伊東細胞の筋線維芽細胞化に伴い発現するNO関連遺伝子のcDNAクローニング

伊東細胞の筋線維芽細胞化に伴い発現するNO関連遺伝子のcDNAクローニング
Paper図書
西原, 利治, 高知医科大学1999-2000<Y151-H11670511>
National Diet Library
  • Subject Headingnon-alcoholic steatohepatitis NASH

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis
Digital博士論文障害者向け資料あり
Enomoto, Masahide, Kaji, Kosuke, Nishimura, Norihisa, Fujimoto, Yuki, Murata, Koji, Takeda, Soichi, Tsuji, Yuki, Fujinaga, Yukihisa, Tanaka, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiElsevier2022-10
National Diet Library
  • Subject HeadingGut-liver axis Lipopolysaccharide Microbiome Non-alcoholic steatohepatitis
  • Note (General)...progression of non-alcoholic steatohepatitis (NASH) pathogenesis, few stud...

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6
Digital博士論文障害者向け資料あり
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences
National Diet Library
  • Subject Headingnon-alcoholic steatohepatitis hepatic fibrogenesis hepatoca...
  • Note (General)...f mortality in non-alcoholic steatohepatitis (NASH)-related cirrhosis. The...

A novel prostaglandin I2 agonist, ONO3 1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice

A novel prostaglandin I2 agonist, ONO3 1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice
Digital博士論文障害者向け資料あり
Motegi, Satoko2022-03-23
National Diet Library
  • Subject HeadingONO-1301 Prostacyclin Prostaglandin I2 Prostaglandin E2 Non-alcoholic steatohepatitis
  • Note (General)...mouse model of non-alcoholic steatohepatitis (NASH). Methods: The therapeu...

日本人高度肥満症患者における非アルコール性脂肪性肝炎と肝線維化に対する腹腔鏡下スリーブ状胃切除術の効果

日本人高度肥満症患者における非アルコール性脂肪性肝炎と肝線維化に対する腹腔鏡下スリーブ状胃切除術の効果
Digital博士論文障害者向け資料あり
中村, 春香Springer2020-07
National Diet Library
  • Subject HeadingNon-alcoholic steatohepatitis Morbid obesity Bariatric surg...
  • Alternative Title...gastrectomy on non-alcoholic steatohepatitis and liver fibrosis in Japanes...
  • Alternative Title...gastrectomy on non-alcoholic steatohepatitis and liver fibrosis in Japanes...

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model. 9 47

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model. 9 47
Digital博士論文障害者向け資料あり
Seki, Kenichiro, Kitade, Mitsuteru, Nishimura, Norihisa, Kaji, Kosuke, Asada, Kiyoshi, Namisaki, Tadashi, Moriya, Kei, Kawaratani, Hideto, Okura, Yasushi, Takaya, Hiroaki, Sawada, Yasuhiko, Sato, Shinya, Nakanishi, Keisuke, Yoshiji, HitoshiImpact Journals2018-06-19Oncotarget
National Diet Library
  • Subject Headingnon-alcoholic steatohepatitis (NASH) fructose hepatocarcino...
  • Note (General)...athogenesis of non-alcoholic steatohepatitis (NASH). Fructose exacerbates ...

Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma

Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma
Digital博士論文障害者向け資料あり
Sato, Takeki2022-03-23
National Diet Library
  • Subject Heading...tin-4 receptor Non-alcoholic steatohepatitis
  • Note (General)The number of patients with non-alcoholic steatohepatitis (NASH) and inflammatory bowel...

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis. 47 12

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis. 47 12
Digital博士論文障害者向け資料あり
Okura, Yasushi, Namisaki, Tadashi, Moriya, Kei, Kitade, Mitsuteru, Takeda, Kosuke, Kaji, Kosuke, Noguchi, Ryuichi, Nishimura, Norihisa, Seki, Kenichiro, Kawaratani, Hideto, Takaya, Hiroaki, Sato, Shinya, Sawada, Yasuhiko, Shimozato, Naotaka, Furukawa, Masanori, Nakanishi, Keisuke, Saikawa, Soichiro, Kubo, Takuya, Asada, Kiyoshi, Yoshiji, HitoshiJohn Wiley & Sons, Inc.2016-12-28Hepatology research
National Diet Library
  • Subject Headinghepatic fibrogenesis hepatocarcinogenesis losartan non-alcoholic steatohepatitis sitagliptin
  • Note (General)...f non-diabetic non-alcoholic steatohepatitis (NASH) in a rat model. METHOD...

Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis. 49 3

Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis. 49 3
Digital博士論文障害者向け資料あり
Sawada, Yasuhiko, Kawaratani, Hideto, Kubo, Takuya, Fujinaga, Yukihisa, Furukawa, Masanori, Saikawa, Soichiro, Sato, Shinya, Seki, Kenichiro, Takaya, Hiroaki, Okura, Yasushi, Kaji, Kosuke, Shimozato, Naotaka, Mashitani, Tsuyoshi, Kitade, Mitsuteru, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yamao, Junichi, Yoshiji, HitoshiWiley2019-03Hepatology research
National Diet Library
  • Subject Heading...tight junction non‐alcoholic steatohepatitis probiotic
  • Note (General)...progression of non-alcoholic steatohepatitis (NASH). Circulating endotoxin...

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis
Digital博士論文
Enomoto, Masahide, Kaji, Kosuke, Nishimura, Norihisa, Fujimoto, Yuki, Murata, Koji, Takeda, Soichi, Tsuji, Yuki, Fujinaga, Yukihisa, Tanaka, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiElsevier2022-10Digestive and liver Disease54 10p.1392-1402
Available onlineOther Libraries in Japan
  • Subject HeadingGut-liver axis Lipopolysaccharide Microbiome Non-alcoholic steatohepatitis
  • Note (General)...progression of non-alcoholic steatohepatitis (NASH) pathogenesis, few stud...

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Digital博士論文
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences21 6p.Article No.2164-
Available onlineOther Libraries in Japan
  • Subject Headingnon-alcoholic steatohepatitis hepatic fibrogenesis hepatoca...
  • Note (General)...f mortality in non-alcoholic steatohepatitis (NASH)-related cirrhosis. The...

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model.

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model.
Digital博士論文
Seki, Kenichiro, Kitade, Mitsuteru, Nishimura, Norihisa, Kaji, Kosuke, Asada, Kiyoshi, Namisaki, Tadashi, Moriya, Kei, Kawaratani, Hideto, Okura, Yasushi, Takaya, Hiroaki, Sawada, Yasuhiko, Sato, Shinya, Nakanishi, Keisuke, Yoshiji, HitoshiImpact Journals2018-06-19Oncotarget9 47p.28638-28651
Available onlineOther Libraries in Japan
  • Subject Headingnon-alcoholic steatohepatitis (NASH) fructose hepatocarcino...
  • Note (General)...athogenesis of non-alcoholic steatohepatitis (NASH). Fructose exacerbates ...

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.
Digital博士論文
Okura, Yasushi, Namisaki, Tadashi, Moriya, Kei, Kitade, Mitsuteru, Takeda, Kosuke, Kaji, Kosuke, Noguchi, Ryuichi, Nishimura, Norihisa, Seki, Kenichiro, Kawaratani, Hideto, Takaya, Hiroaki, Sato, Shinya, Sawada, Yasuhiko, Shimozato, Naotaka, Furukawa, Masanori, Nakanishi, Keisuke, Saikawa, Soichiro, Kubo, Takuya, Asada, Kiyoshi, Yoshiji, HitoshiJohn Wiley & Sons, Inc.2016-12-28Hepatology research47 12p.1317-1328
Available onlineOther Libraries in Japan
  • Subject Headinghepatic fibrogenesis hepatocarcinogenesis losartan non-alcoholic steatohepatitis sitagliptin
  • Note (General)...f non-diabetic non-alcoholic steatohepatitis (NASH) in a rat model. METHOD...

Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis.

Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis.
Digital博士論文
Sawada, Yasuhiko, Kawaratani, Hideto, Kubo, Takuya, Fujinaga, Yukihisa, Furukawa, Masanori, Saikawa, Soichiro, Sato, Shinya, Seki, Kenichiro, Takaya, Hiroaki, Okura, Yasushi, Kaji, Kosuke, Shimozato, Naotaka, Mashitani, Tsuyoshi, Kitade, Mitsuteru, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yamao, Junichi, Yoshiji, HitoshiWiley2019-03Hepatology research49 3p.284-295
Available onlineOther Libraries in Japan
  • Subject Heading...tight junction non‐alcoholic steatohepatitis probiotic
  • Note (General)...progression of non-alcoholic steatohepatitis (NASH). Circulating endotoxin...

新規プロスタグランジンI2アゴニストであるONO-1301は非アルコール性脂肪性肝炎モデルマウスにおいて肝臓の炎症と線維化を改善する

新規プロスタグランジンI2アゴニストであるONO-1301は非アルコール性脂肪性肝炎モデルマウスにおいて肝臓の炎症と線維化を改善する
Digital博士論文
茂木, 聡子
Available onlineOther Libraries in Japan
  • Summary, etc....mouse model of non-alcoholic steatohepatitis (NASH). Methods: The therapeu...
  • Subject HeadingONO-1301 Prostacyclin Prostaglandin I2 Prostaglandin E2 Non-alcoholic steatohepatitis
  • Alternative Title...es fibrosis in non-alcoholic steatohepatitis model mice

肝細胞癌の早期発症に重度の肝脂肪化と軽度大腸炎が重要

肝細胞癌の早期発症に重度の肝脂肪化と軽度大腸炎が重要
Digital博士論文
佐藤, 毅昂
Available onlineOther Libraries in Japan
  • Summary, etc.The number of patients with non-alcoholic steatohepatitis (NASH) and inflammatory bowel...
  • Subject Heading...tin-4 receptor Non-alcoholic steatohepatitis

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Digital博士論文
山村, 咲良
Available onlineOther Libraries in Japan
  • Subject Heading... liver disease non-alcoholic steatohepatitis significant hepatic fibrosis ...

Reached to the end of result.

RSS